An implantable infusion pump is a medical device used to deliver the drug to the patients through intra-arterial, intravenous, subcutaneous, intrathecal route, intraperitoneal, and epidural. The implantable infusion pump is surgically set in a subcutaneous pocket in the abdominal wall, and a catheter is strung into the desired place. The primary capacity of an implantable infusion pump is to convey fluids, for example, supplements, and drugs, into a patient's body in a controlled fashion. The dosage is individually adapted to each patient. The implantable infusion pumps need only to be refilled every 1 to 3 months. Medication application with the new implantable infusion pumps is dependable also, with no risk to drug addiction. Reactions are decreased to a very minimum level. Driving functional mechanisms of implantable infusion pumps may include fluorocarbon propellant, peristalsis, osmotic pressure, and piezoelectric disk benders.
MARKET DYNAMICS
The implantable infusion pumps market has shown a significant evolution over the forecast period. The primary factors driving the market include the growing prevalence of cancer cases, diabetes, and obesity worldwide. Also, a significant rise in implantable drug delivery procedures through surgeries is responsible for the rising demand for infusion pumps. The primary practices include the delivery of analgesics and chemotherapy agents. Various implantable infusion pumps are industrially accessible to the end-users, which will drive the demand at a substantial rate during the forecast period. Moreover, the advancement in technology and increase spending by manufacturers for the production of more improved implantable infusion pumps will also boost the growth of this market. Conversely, stringent FDA policies for the approval of implantable infusion pumps will impede this market's growth. Additionally, patient safety risks and medication errors while drug delivery associated with implantable infusion pumps in the desirable locations may constrain the overall development of the market.
MARKET SCOPE
The "Implantable Infusion Pumps Market Analysis to 2028" is a specialized and in-depth study of the medical device in the healthcare industry, with a specific focus on the global market trend analysis. This report provides an outline of the implantable infusion pumps market with detailed market segmentation by product, application, and end-user. The implantable infusion pumps market is estimated to witness high growth during the forecast period. It focuses on the vital statistics on the market status of the leading players in the implantable infusion pumps market and offers key opportunities and trends in the market.
MARKET SEGMENTATION
The market is categorized based on the product, application, and end user. Based on the product, the market is segmented as piston type infusion pumps and creeping type infusion pumps. Based on the application, the segmentation of the market is into oncology, paediatrics, haematology, diabetes mellitus, and others. Based on end user, segmentation of the market is into hospitals, ambulatory surgical centers, specialty clinics, and others.
REGIONAL FRAMEWORK
The report states a detailed outline of the industry, consisting of both qualitative and quantitative information. It gives a sketch and forecast of the implantable infusion pumps market based on various segments.
The report also consists of market size and forecast estimates from the year 2020 to2028with respect to five primary regions, namely; North America, Asia-Pacific (APAC), Europe, Middle East, and Africa (MEA), and South & Central America (SCAM). The implantable infusion pumps market by each region is then subdivided into respective countries and segments. It offers the analysis and forecast of 18 countries worldwide and the recent trend and opportunities prevailing in the region.
The report analyzes factors affecting the implantable infusion pumps market from both the demand and supply sides. Furthermore, it assesses market dynamics affecting the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also comprises a precise PEST analysis for all five regions, namely; North America, APAC, Europe, MEA, and South & Central America, after evaluating political, social, economic, and technological factors affecting the implantable infusion pumps market in these regions.
MARKET PLAYERS
The report contains critical developments in the implantable infusion pumps market as inorganic and organic growth strategies. Various companies are pivoting on organic growth strategies like product approvals, product launches, and others, such as events and patents. Inorganic growth strategies noticed in the market were acquisitions and collaborations &partnerships. Such activities have paved the path for the expansion of the business and customer base of market players. The market players from the implantable infusion pumps market are anticipated to have profitable growth opportunities in the following years with the increasing demand for implantable infusion pumps in the global market. Below mentioned is the list of a few companies engaged in the implantable infusion pumps market.
The report also offers key players' profiles in the implantable infusion pumps market, along with their SWOT analysis and market strategies. Also, the report focuses on leading market players with information on company profiles, financial information of the last three years, components, and services provided, critical development in the past five years.
- Medtronic
- BD
- Baxter
- ICU Medical, Inc.
- B. Braun Melsungen AG
- Fresenius SE & Co.
- Smiths Medical
- Terumo Corporation
- Moog Inc.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
The Insight Partner's dedicated research and analysis team comprises of experienced professionals with advanced statistical expertise and offers various customization options in the current study.